ad

3 Product Engineering Firm, Solar Modules Maker and Multi Speciality Hospitals Network Stocks With a Strong Future Roadmap: Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences

Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences: ROE of 10.7% to 26.2% and FY22 to FY26 revenue CAGR of 23.8% to 65.1%. Prices as of 3 Nov 2026.


4 Nov 2026 • 1:29 pm

3 Product Engineering Firm, Solar Modules Maker and Multi Speciality Hospitals Network Stocks With a Strong Future Roadmap: Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences

Quick Answer

The three product engineering, solar and hospital stocks to watch are Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences. Their return on equity ranges from 10.7% to 26.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 23.8% to 65.1%. Saatvik Green Energy leads on both return on equity at 26.2% and revenue growth at 65.1% a year. Prices are based on the 3 November 2026 close, and this article is educational, not investment advice.

Product engineering, solar and hospital stocks offer a focused view of a sector where demand keeps widening. Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences cover a product engineering services company, a solar modules maker and a multi speciality hospitals network.

This list covers three product engineering, solar and hospital stocks with complete current figures: Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences. Every figure comes from the latest reported financials and the 3 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Product Engineering, Solar and Hospital Stocks?

Product engineering, solar and hospital stocks are listed companies that build software products and platforms for global clients, make solar modules and cells for utility and rooftop projects, and run multi-speciality hospitals across Telangana, Andhra Pradesh and other states. Their earnings depend on client technology budgets, solar installations and patient volumes.

Product Engineering, Solar and Hospital Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Persistent Systems 6,097 90,857 50.4 17.9 21.0 0.07
Saatvik Green Energy 357.75 4,934 20.1 43.9 26.2 0.69
Krishna Institute of Medical Sciences 730.5 28,495 146.5 59.6 10.7 1.89

On valuation, Saatvik Green Energy trades at a P/E below the industry P/E, while Persistent Systems and Krishna Institute of Medical Sciences trade above it, which reflects the growth the market already expects. Readers comparing product engineering, solar and hospital stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Product Engineering, Solar and Hospital Stocks Have a Strong Roadmap in India?

Product engineering, solar and hospital stocks have a strong roadmap in India because rising digital engineering demand, large solar capacity plans and growing demand for quality hospital care keep widening the market for these companies.

  • Product engineering. Clients build new platforms on cloud and AI.
  • Solar modules. Rooftop and utility projects add demand.
  • Hospitals. Wider insurance cover brings more patients.

Why Persistent Systems Features Among These Product Engineering, Solar and Hospital Stocks

Among the product engineering, solar and hospital stocks on this list, Persistent Systems is a Pune-based technology services and digital engineering company that builds software products and platforms for clients in banking, healthcare, software and hi-tech industries worldwide.

Revenue rose from Rs 5,855 crore in FY22 to Rs 14,929 crore in FY26, a compound annual growth rate of 26.4%. Net profit grew from Rs 690 crore in FY22 to Rs 1,865 crore in FY26, which works out to a compound annual growth rate of 28.2%.

The company has a return on equity of 21.0%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 90,857 crore. The stock trades at a P/E of 50.4, above the industry P/E of 17.9.

Roadmap: The company is deepening its work in cloud, data and artificial intelligence, where enterprises are raising spending. A strong base of long-term clients helps it win larger engineering programmes.

What to watch: Track large deal wins, client additions and the share of artificial intelligence work in revenue.

Why Saatvik Green Energy Features Among These Product Engineering, Solar and Hospital Stocks

Among the engineering and solar care shares on this list, Saatvik Green Energy is a Haryana-based manufacturer of solar photovoltaic modules and cells that supplies utility-scale, commercial and rooftop solar projects.

The company has a return on equity of 26.2%, a debt to equity ratio of 0.69 and a market capitalisation of Rs 4,934 crore. The stock trades at a P/E of 20.1, below the industry P/E of 43.9.

Revenue rose from Rs 618 crore in FY22 to Rs 4,588 crore in FY26, a compound annual growth rate of 65.1%. Net profit grew from Rs 217 crore in FY25 to Rs 357 crore in FY26, a rise of 64.5%.

Roadmap: The company is adding module and cell capacity to meet rising demand for locally made solar equipment and is building a more integrated production chain. India's solar capacity targets support a steady flow of orders.

What to watch: Track capacity additions, order book growth and solar policy support.

Why Krishna Institute of Medical Sciences Features Among These Product Engineering, Solar and Hospital Stocks

Among the three companies on this list, Krishna Institute of Medical Sciences, known as KIMS Hospitals, runs a network of multi-specialty hospitals in Telangana, Andhra Pradesh and other states, with strengths in cardiac, neuro and transplant care.

Revenue rose from Rs 1,671 crore in FY22 to Rs 3,931 crore in FY26, a compound annual growth rate of 23.8%. Net profit for FY26 was Rs 242 crore, a net margin of 6.2%.

In the June 2026 quarter, revenue grew 36.1% year on year to Rs 1,196 crore. The company has a return on equity of 10.7%, a debt to equity ratio of 1.89 and a market capitalisation of Rs 28,495 crore. The stock trades at a P/E of 146.5, above the industry P/E of 59.6.

Roadmap: The company is adding beds in existing clusters and opening hospitals in new cities across southern and central India. Rising insurance cover and demand for advanced procedures support growth in patient volumes.

What to watch: Track bed additions, occupancy and revenue per occupied bed.

Persistent Systems vs Saatvik Green Energy vs Krishna Institute of Medical Sciences on Key Financials

The table below sets the three product engineering, solar and hospital stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Persistent Systems 5,855 14,929 26.4% 1,865 12.5%
Saatvik Green Energy 618 4,588 65.1% 357 7.8%
Krishna Institute of Medical Sciences 1,671 3,931 23.8% 242 6.2%

Saatvik Green Energy posts the highest return on equity in this group at 26.2%. Persistent Systems has the largest FY26 revenue at Rs 14,929 crore, and Saatvik Green Energy shows the fastest revenue growth with a 65.1% compound annual rate. A useful habit with product engineering, solar and hospital stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Product Engineering, Solar and Hospital Stocks

Every theme carries risks that deserve a check before any decision. For these product engineering, solar and hospital stocks, the main points are: Long-term engineering and solar care shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Client spending. Technology budgets can vary with global conditions.
  • Module prices. Solar equipment prices and policy support can change returns.
  • Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter product engineering, solar and hospital stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Product Engineering, Solar and Hospital Stocks

Product engineering, solar and hospital stocks reward patient research into demand, execution and financial strength. Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences each have a clear plan to grow. Based on the 3 November 2026 close, Persistent Systems trades at Rs 6,097, Saatvik Green Energy at Rs 357.75 and Krishna Institute of Medical Sciences at Rs 730.5.

Download the Univest iOS App or Univest Android App to track product engineering, solar and hospital stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are product engineering, solar and hospital stocks?

Ans. Product engineering, solar and hospital stocks are listed companies that build software products and platforms for global clients, make solar modules and cells for utility and rooftop projects, and run multi-speciality hospitals across Telangana, Andhra Pradesh and other states. Their earnings depend on client technology budgets, solar installations and patient volumes. This list looks at three of them, Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences, using reported FY22 to FY26 financials and the 3 November 2026 closing prices.

Which product engineering, solar and hospital stocks are covered in this list?

Ans. This list covers Persistent Systems, Saatvik Green Energy and Krishna Institute of Medical Sciences. Based on the 3 November 2026 close, Persistent Systems traded at Rs 6,097, Saatvik Green Energy at Rs 357.75 and Krishna Institute of Medical Sciences at Rs 730.5. Their return on equity ranges from 10.7% to 26.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 23.8% to 65.1%.

Why do product engineering, solar and hospital stocks have a strong future roadmap in India?

Ans. Product engineering, solar and hospital stocks have a strong roadmap in India because rising digital engineering demand, large solar capacity plans and growing demand for quality hospital care keep widening the market for these companies. The main drivers are as follows. Product engineering. Clients build new platforms on cloud and AI. Solar modules. Rooftop and utility projects add demand. Hospitals. Wider insurance cover brings more patients. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Persistent Systems performed financially?

Ans. Revenue rose from Rs 5,855 crore in FY22 to Rs 14,929 crore in FY26, a compound annual growth rate of 26.4%. Net profit grew from Rs 690 crore in FY22 to Rs 1,865 crore in FY26, which works out to a compound annual growth rate of 28.2%. The company has a return on equity of 21.0%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 90,857 crore. The stock trades at a P/E of 50.4, above the industry P/E of 17.9. Looking ahead, the company is deepening its work in cloud, data and artificial intelligence, where enterprises are raising spending. A strong base of long-term clients helps it win larger engineering programmes.

How has Saatvik Green Energy performed financially?

Ans. Revenue rose from Rs 618 crore in FY22 to Rs 4,588 crore in FY26, a compound annual growth rate of 65.1%. Net profit grew from Rs 217 crore in FY25 to Rs 357 crore in FY26, a rise of 64.5%. The company has a return on equity of 26.2%, a debt to equity ratio of 0.69 and a market capitalisation of Rs 4,934 crore. The stock trades at a P/E of 20.1, below the industry P/E of 43.9. Looking ahead, the company is adding module and cell capacity to meet rising demand for locally made solar equipment and is building a more integrated production chain. India's solar capacity targets support a steady flow of orders.

How has Krishna Institute of Medical Sciences performed financially?

Ans. Revenue rose from Rs 1,671 crore in FY22 to Rs 3,931 crore in FY26, a compound annual growth rate of 23.8%. Net profit for FY26 was Rs 242 crore, a net margin of 6.2%. In the June 2026 quarter, revenue grew 36.1% year on year to Rs 1,196 crore. The company has a return on equity of 10.7%, a debt to equity ratio of 1.89 and a market capitalisation of Rs 28,495 crore. The stock trades at a P/E of 146.5, above the industry P/E of 59.6. Looking ahead, the company is adding beds in existing clusters and opening hospitals in new cities across southern and central India. Rising insurance cover and demand for advanced procedures support growth in patient volumes.

What risks should investors check before buying product engineering, solar and hospital stocks?

Ans. Investors should check a few risks before buying product engineering, solar and hospital stocks. Client spending. Technology budgets can vary with global conditions. Module prices. Solar equipment prices and policy support can change returns. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of product engineering, solar and hospital stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 3 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down